- ASCO® 2024
- Yale Cancer Answers
- ASH CME Series
- Smilow Shares with Primary Care
- Grand Rounds
- Head and Neck
- Gynecologic
- Benign Hematology
- Breast
- GI
- Lung
- GU
- Hematologic Oncology
- Brain
- Cancer Screening
- DEI (Diversity, Equity and Inclusion)
- 2021 ASH Highlights
- General Events
- Events
Playback speed
10 seconds
Yale ASH Updates on the Randomized Controlled Phase 3 ALIFE2 Study: Low-Molecular-Weight Heparin for Women With Recurrent Miscarriage and Inherited Thrombophilia
By
Yale Cancer Center
FEATURING
Layla Van Doren
By
Yale Cancer Center
FEATURING
Layla Van Doren
48 views
March 15, 2023
Comments 0
Login to view comments.
Click here to Login
ASH CME Series